In this episode, guest Kevin Bittorf, founder of the Advancing Drug Development Forum and Dawn Dickerson sat down with host Alok Tayi to discuss trends in modern manufacturing and pharmaceutical environments.
Read More
Jon Hennek co-leads the Systems Innovation Team at Indigo Ag. He co-founded the team—whose mission is to create a vision for what agriculture could look like in the distant future and develop a strategy for the Indigo model to dramatically accelerate its adoption—in 2017 while at Flagship Pioneering.
Read More
Sven Karlsson is the co-founder, chief operating officer and chief business officer of Platelet BioGenesis. He has more than a decade of experience in business development and financial analysis.
In this episode of Biotech2050, Sven talks about his background, how he came to founding Platelet BioGenesis and the problems he and his team are trying to solve with the world's only method of producing clinical-grade human platelets from induced pluripotent stem cells.
Read More
Dr. Jo Viney is an entrepreneurial scientist and experienced biotech executive. A self-described “drug-hunter”, she has successfully advanced a number of programs into the clinic.
She is the is Co-Founder, President and CSO of Pandion Therapeutics, a biotech company focused on developing new therapies for treating autoimmune and inflammatory diseases.
Read More
John Keilty is the Chief Data Sciences Officer at Decibel Therapeutics and a Strategic advisor at Third Rock Ventures. He is a biologist and bioinformatics guy by training and has been active in the biotech space for over two decades. In his career, John has been responsible for building out genomix, and genetics capabilities for early stage biotech companies.
Read More
In this inaugural episode of Biotech2050, hosts Alok Tayi and Rahul Chatuverdi sits down with Lee Cooper, a seasoned biotech entrepreneur, patient advocate, and Founder of Enlight Bio to talk about the importance of patient centricity in today’s modern biotech.
Read More
This episode is the trailer launching our highly anticipated podcast, Biotech 2050. A Think Tank chronicling the disruptions changing the biotech industry over the next 50 years.
Read More